News

Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
Union trustees allege health plan documents didn’t allow for $4.3 million in drug spending that was cleared by pharmacy ...